PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-11.50%
Both yoy net incomes decline, with MRVL at -94.74%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
3.51%
Less D&A growth vs. MRVL's 159.02%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
21.57%
Some yoy growth while MRVL is negative at -2798.79%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
3.10%
Less SBC growth vs. MRVL's 149.00%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-1428.57%
Both reduce yoy usage, with MRVL at -51.72%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-889.29%
AR is negative yoy while MRVL is 97.14%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-14550.00%
Negative yoy inventory while MRVL is 56.19%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
581.82%
A yoy AP increase while MRVL is negative at -201.84%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
250.96%
Some yoy usage while MRVL is negative at -262.67%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-75.00%
Negative yoy while MRVL is 3798.88%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-36.82%
Both yoy CFO lines are negative, with MRVL at -51.90%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-9.32%
Both yoy lines negative, with MRVL at -55.61%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
7.21%
Less growth in investment purchases vs. MRVL's 96.10%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
915.44%
Proceeds from sales/maturities above 1.5x MRVL's 150.93%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
80.31%
Growth well above MRVL's 104.57%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
77.33%
We have mild expansions while MRVL is negative at -1015.29%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
89.92%
Buyback growth below 50% of MRVL's 8021.17%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.